The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Manry J,Bastard P,Gervais A,Le Voyer T,Rosain J,Philippot Q,Michailidis E,Hoffmann H,Eto S,Garcia-Prat M,Bizien L,Parra-Martínez A,Yang R,Haljasmägi L,Migaud M,Särekannu K,Maslovskaja J,de Prost N,Tandjaoui-Lambiotte Y,Luyt C,Amador-Borrero B,Gaudet A,Poissy J,Morel P,Richard P,Cognasse F,Troya J,Trouillet-Assant S,Belot A,Saker K,Garçon P,Rivière J,Lagier J,Gentile S,Rosen L,Shaw E,Morio T,Tanaka J,Dalmau D,Tharaux P,Sene D,Stepanian A,Mégarbane B,Triantafyllia V,Fekkar A,Heath J,Franco J,Anaya J,Solé-Violán J,Imberti L,Biondi A,Bonfanti P,Castagnoli R,Delmonte O,Zhang Y,Snow A,Holland S,Biggs C,Moncada-Vélez M,Arias A,Lorenzo L,Boucherit S,Anglicheau D,Planas A,Haerynck F,Duvlis S,Ozcelik T,Keles S,Bousfiha A,El Bakkouri J,Ramirez-Santana C,Paul S,Pan-Hammarström Q,Hammarström L,Dupont A,Kurolap A,Metz C,Aiuti A,Casari G,Lampasona V,Ciceri F,Barreiros L,Dominguez-Garrido E,Vidigal M,Zatz M,van de Beek D,Sahanic S,Tancevski I,Stepanovskyy Y,Boyarchuk O,Nukui Y,Tsumura M,Vidaur L,Tangye S,Burrel S,Duffy D,Quintana-Murci L,Klocperk A,Kann N,Shcherbina A,Lau Y,Leung D,Coulongeat M,Marlet J,Koning R,Reyes L,Chauvineau-Grenier A,Venet F,Monneret G,Nussenzweig M,Arrestier R,Boudhabhay I,Baris-Feldman H,Hagin D,Wauters J,Meyts I,Dyer A,Kennelly S,Bourke N,Halwani R,Sharif-Askari F,Dorgham K,Sallette J,Sedkaoui S,AlKhater S,Rigo-Bonnin R,Morandeira F,Roussel L,Vinh D,Erikstrup C,Condino-Neto A,Prando C,Bondarenko A,Spaan A,Gilardin L,Fellay J,Lyonnet S,Bilguvar K,Lifton R,Mane S,Anderson M,Boisson B,Béziat V,Zhang S,Andreakos E,Hermine O,Pujol A,Peterson P,Mogensen T,Rowen L,Mond J,Debette S,de Lamballerie X,Burdet C,Bouadma L,Zins M,Soler-Palacin P,Colobran R,Gorochov G,Solanich X,Susen S,Martinez-Picado J,Raoult D,Vasse M,Gregersen P,Piemonti L,Rodríguez-Gallego C,Notarangelo L,Su H,Kisand K,Okada S,Puel A,Jouanguy E,Rice C,Tiberghien P,Zhang Q,Casanova J,Abel L,Cobat A
Source :
Pmid / DOI: